EHP.L Share News (EHP)

6 Aug 2012

EpiStem, the pre-clinical drugs test firm, has reported that full year trading has been broadly in-line with market forecasts. The firm also said it ...

5 Jul 2012

Biotechnology firm Epistem Hldings said it had received the go-ahead to sells its new tuberculosis product in EEA member state markets. The firm said ...

11 Oct 2011

Epistem, the biotechnology company specialising in diagnostic aids for the treatment of cancer and gastrointestinal diseases, continued on its steady ...

29 Mar 2011

Adult stem cell specialist Epistem scraped into profit in the first half of its financial year. The company, which made its maiden full year profit l...

5 Oct 2010

UK biotech company, Epistem, celebrates the full year results with a maiden pre-tax profit since becoming an AIM-listed company in 2007. The group ha...

29 Jul 2010

Blinds specialist Titon's revenues for the 3 months to June were 19% higher than the corresponding period last year, with UK sales 15% higher and the ...

29 Jul 2010

LONDON (Dow Jones)--Epistem Holdings PLC (EHP.LN), a biotechnology company, said Thursday that trading over the year was in line with market forecasts...

9 Mar 2010

The Novel Therapies division is threatening to steal the show at epithelial stem cells specialist Epistem, as the benefits of its transformational dea...